Advertisement

Topics

FDA Approves Alnylam's Rare Disease Drug

17:19 EDT 10 Aug 2018 | FinanzNachrichten

WASHINGTON (dpa-AFX) - The U.S. Food and Drug Administration Friday approved Onpattro, Alnylam Pharmaceuticals Inc.'s (ALNY) rare disease drug. The approval makes it the first approval of a therap...

Original Article: FDA Approves Alnylam's Rare Disease Drug

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Alnylam's Rare Disease Drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...